Patents by Inventor Jean-Christophe Peter

Jean-Christophe Peter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies against tropomyosin-related kinase B receptors
    Patent number: 9028820
    Abstract: The invention relates to monoclonal antibodies directed to a particular part of tropomyosin-related kinase B receptor (TrkB) and hybridoma cell lines producing these. Fragments of these antibodies, in particular fragments representing complementarity determining regions (CDRs), and proteins comprising these, are useful in a method of treating cancer, pain, anorexia, anorexia nervosa and/or cachexia.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: May 12, 2015
    Assignee: University of Basel
    Inventors: Karl Hofbauer, Jean-Christophe Peter
  • ANTIBODIES AGAINST TROPOMYOSIN-RELATED KINASE B RECEPTORS
    Publication number: 20140112928
    Abstract: The invention relates to monoclonal antibodies directed to a particular part of tropomyosin-related kinase B receptor (TrkB) and hybridoma cell lines producing these. Fragments of these antibodies, in particular fragments representing complementarity determining regions (CDRs), and proteins comprising these, are useful in a method of treating cancer, pain, anorexia, anorexia nervosa and/or cachexia.
    Type: Application
    Filed: May 18, 2012
    Publication date: April 24, 2014
    Applicant: UNIVERSITY OF BASEL
    Inventors: Karl Hofbauer, Jean-Christophe Peter
  • Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
    Patent number: 8703139
    Abstract: Disclosed are monoclonal antibodies, binding fragments, and derivatives thereof directed to the human melanocortin-4 receptor, as well as pharmaceutical compositions including the same, the therapeutic uses, including methods for treating cachexia and related conditions and diseases, using such monoclonal antibodies, binding fragments, derivatives, and pharmaceutical compositions.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: April 22, 2014
    Assignee: Universitaet Basel
    Inventors: Karl Hofbauer, Jean Christophe Peter
  • MONOCLONAL ANTIBODIES AND BINDING FRAGMENTS THEREOF DIRECTED TO THE MELANOCORTIN-4 RECEPTOR AND THEIR USE IN THE TREATMENT OF CACHEXIA AND RELATED CONDITIONS AND DISEASES
    Publication number: 20130058941
    Abstract: Disclosed are monoclonal antibodies, binding fragments, and derivatives thereof directed to the human melanocortin-4 receptor, as well as pharmaceutical compositions including the same, the therapeutic uses, including methods for treating cachexia and related conditions and diseases, using such monoclonal antibodies, binding fragments, derivatives, and pharmaceutical compositions.
    Type: Application
    Filed: July 27, 2012
    Publication date: March 7, 2013
    Applicant: UNIVERSITAET BASEL
    Inventors: Karl HOFBAUER, Jean Christophe PETER
  • Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
    Patent number: 8252908
    Abstract: Disclosed are monoclonal antibodies, binding fragments, and derivatives thereof directed to the human melanocortin-4 receptor, as well as pharmaceutical compositions including the same, and therapeutic uses, including methods for treating cachexia and related conditions and diseases, using such monoclonal antibodies, binding fragments, derivatives, and pharmaceutical compositions.
    Type: Grant
    Filed: December 30, 2008
    Date of Patent: August 28, 2012
    Assignee: Universitaet Basel
    Inventors: Karl Hofbauer, Jean-Christophe Peter
  • Auto-antibodies against the melanocortin-4 receptor
    Patent number: 8008446
    Abstract: Disclosed are biological markers for obesity and methods for diagnosing and treating obesity and related conditions by detecting and modulating the activity of auto-antibodies against the melanocortin-4 receptor or a portion of the melanocortin-4 receptor. Also disclosed are methods for discovering new therapeutics which modulate the activity of auto-antibodies against the melanocortin-4 receptor or a portion of the melanocortin-4 receptor, in particular which prevent the binding of auto-antibodies against the melanocortin-4 receptor or a portion of the melanocortin-4 receptor.
    Type: Grant
    Filed: December 31, 2008
    Date of Patent: August 30, 2011
    Assignee: University of Basel
    Inventors: Karl Hofbauer, Jean-Christophe Peter
  • METHODS FOR DIAGNOSING AND TREATING OBESITY BY MODULATING THE ACTIVITY OF AUTO-ANTIBODIES AGAINST THE MELANOCORTIN-4 RECEPTOR
    Publication number: 20090191219
    Abstract: Disclosed are biological markers for obesity and methods for diagnosing and treating obesity and related conditions by detecting and modulating the activity of auto-antibodies against the melanocortin-4 receptor or a portion of the melanocortin-4 receptor. Also disclosed are methods for discovering new therapeutics which modulate the activity of auto-antibodies against the melanocortin-4 receptor or a portion of the melanocortin-4 receptor, in particular which prevent the binding of auto-antibodies against the melanocortin-4 receptor or a portion of the melanocortin-4 receptor.
    Type: Application
    Filed: December 31, 2008
    Publication date: July 30, 2009
    Inventors: Karl Hofbauer, Jean-Christophe Peter